These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24121994)

  • 1. Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results.
    Mesples A; Majeed N; Zhang Y; Hu X
    Med Sci Monit; 2013 Oct; 19():852-7. PubMed ID: 24121994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of Autoantibodies Following Autologous Hematopoietic Stem Cell Transplantation in 6 Children with Recently Diagnosed Type 1 Diabetes Mellitus.
    Mesples AD; Cox DCT; Lundy HD; Antonio-Collie S; Diggiss CW; Lakey JRT
    Med Sci Monit; 2023 Jan; 29():e938979. PubMed ID: 36659834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
    JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
    Couri CE; Oliveira MC; Stracieri AB; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Martinez EZ; Foss MC; Burt RK; Voltarelli JC
    JAMA; 2009 Apr; 301(15):1573-9. PubMed ID: 19366777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
    Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
    Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
    Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
    Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.
    Dave SD; Vanikar AV; Trivedi HL; Thakkar UG; Gopal SC; Chandra T
    Clin Exp Med; 2015 Feb; 15(1):41-5. PubMed ID: 24317657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ; Elliott RB; Mackay IR; Tuomi T; Rowley MJ; Pilcher CC; Knowles WJ
    Diabet Med; 1994 Nov; 11(9):866-71. PubMed ID: 7705024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.
    Cai J; Wu Z; Xu X; Liao L; Chen J; Huang L; Wu W; Luo F; Wu C; Pugliese A; Pileggi A; Ricordi C; Tan J
    Diabetes Care; 2016 Jan; 39(1):149-57. PubMed ID: 26628416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
    Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
    Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment.
    Cabrera-Rode E; Perich P; Diaz-Horta O; Tiberti C; Molina G; Arranz C; Martin JM; Licea M; De Leiva AD; Puig-Domingo M; Dimario U
    Autoimmunity; 2002 Nov; 35(7):469-74. PubMed ID: 12685875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
    Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
    Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.